Life-saving Treatment Method for NAFLD
Non-alcoholic fatty liver disease (NAFLD) is gradually becoming a global epidemic. The number of adults, and even children, being diagnosed with this silent killer skyrocketed like never before. Due to the broad spectrum of liver conditions that NAFLD includes (fatty liver and NASH), a recent research suggests that personalized risk prognosis and individualized treatment is needed in order to treat NAFLD more effectively.
Various health problems complicate the treatment method
A research published in The Lancet (an international medical journal founded in 1823) mentions that personalized therapies should be given to NAFLD patients due to the fact that there are different factors contributing to and influencing NAFLD. Diabetes and obesity are the major factors. And in some cases, NAFLD is genetically determined. For some more complicated cases, patients might have diabetes and cardiovascular disease at the same time.
Currently, there is still not a direct cure that can treat NAFLD completely. NAFLD patients are often suggested to change their lifestyle and diet. However, in some cases, losing weight alone may not benefit much or it simply is not an option for people with cardiovascular diseases who cannot engage in too much exercise.
All these together make treating NAFLD extra challenging, as many different factors have to be taken into account, especially when the general treatment is often targeted at a large group of patients instead of focusing on the needs of each type of patients.
A tailored approach is always the best approach
Since everyone’s health and liver condition is different, personalized treatment is always the best treatment when it comes to managing NAFLD. Due to the nature of NAFLD, medications with fixed dosage may not suit patients with various needs and health concerns. Customized treatments that target liver inflammation (which is the cause of NAFLD in the first place) and that allow flexible dosage for NAFLD often produces better liver improvement results. Contact us for more information about tailored liver therapy for NAFLD at support@kyotsujigyo.net.
- Science Daily, https://www.sciencedaily.com/releases/2018/08/180831110419.htm, (Accessed Date: 2018-09-07)
- National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/pubmed/29969922, (Accessed Date: 2018-09-07)
- The Lancet, https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30154-2/fulltext, (Accessed Date: 2018-09-07)
- * All research and clinical data should be used as reference purposes only, results may vary.